Zobrazeno 1 - 9
of 9
pro vyhledávání: '"J. T. Sahlroot"'
Autor:
Iftekhar Mahmood, J T Sahlroot
Publikováno v:
Biopharmaceutics & Drug Disposition. 18:117-126
A limited sampling model has been developed for flunarizine following a 30 mg oral dose in epileptic patients who were receiving phenytoin or carbamazepine or both, to estimate the area under the curve (AUC) and maximum plasma concentration (Cmax). T
Autor:
D. Hoberman, J. T. Sahlroot
Publikováno v:
Clinical Trials in Neurology ISBN: 9781849968560
Human beings are anything but homogeneous experimental units. No matter how rigorous the effort to restrict a pool of patient candidates for a controlled clinical trial, even an effective treatment accounts for only a small portion of the resulting r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::565c164902829403451c7d4aee156710
https://doi.org/10.1007/978-1-4471-3787-0_10
https://doi.org/10.1007/978-1-4471-3787-0_10
Autor:
J T, Sahlroot, G W, Pledger
Publikováno v:
Advances in neurology. 76
Autor:
I, Mahmood, J T, Sahlroot
Publikováno v:
Biopharmaceuticsdrug disposition. 18(2)
A limited sampling model has been developed for flunarizine following a 30 mg oral dose in epileptic patients who were receiving phenytoin or carbamazepine or both, to estimate the area under the curve (AUC) and maximum plasma concentration (Cmax). T
Autor:
C. B. McCutchen, Michael Privitera, David M. Treiman, Gordon W. Pledger, Adrian Handforth, J. T. Sahlroot, J. H. Wood, James J. Cereghino, M. S. Linde
Publikováno v:
Neurology. 44(8)
Background: Dezinamide (DZM, ADD 94057) is a potential antiepileptic drug that binds to the voltage-sensitive sodium channel and showed preliminary evidence of efficacy and safety in an open-label study.Methods: Our double-blind, placebo-controlled t
Autor:
G W, Pledger, J T, Sahlroot
Publikováno v:
Epilepsy research. Supplement. 10
Autor:
J. Y. Tsay, Nina M. Graves, Philip H. Sheridan, Fritz E. Dreifuss, T. L. Sierzant, G. Cooper, Margaret Jacobs, I. Drury, Gordon W. Pledger, Soo Ik Lee, E. Bertram, James J. Cereghino, Ilo E. Leppik, Nancy Santilli, M. Ashworth, J. T. Sahlroot
Publikováno v:
Neurology. 41:1785-1785
Felbamate (2-phenyl-1,3-propanediol dicarbamate) has a favorable preclinical profile in animal models of epilepsy. We present the results of a double-blind, randomized, placebo-controlled clinical trial in patients with partial seizures. Criteria for
Publikováno v:
Journal of the American Dietetic Association. 85:77-79
Publikováno v:
Journal of the American Dietetic Association. 85(1)